UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1358) 1358
Book Chapter (65) 65
Newspaper Article (34) 34
Newsletter (23) 23
Magazine Article (4) 4
Transcript (3) 3
Streaming Video (2) 2
Dissertation (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
darbepoetin alfa (1305) 1305
humans (1028) 1028
erythropoietin - analogs & derivatives (923) 923
science & technology (903) 903
life sciences & biomedicine (886) 886
erythropoietin - therapeutic use (633) 633
anemia - drug therapy (621) 621
male (598) 598
female (556) 556
anemia (502) 502
middle aged (427) 427
hematinics - therapeutic use (420) 420
aged (403) 403
erythropoietin - administration & dosage (389) 389
anemia - etiology (360) 360
recombinant proteins (356) 356
erythropoietin (299) 299
epoetin alfa (296) 296
treatment outcome (268) 268
urology & nephrology (246) 246
adult (237) 237
hematinics - administration & dosage (234) 234
erythropoietin - adverse effects (224) 224
hemoglobin (184) 184
drug administration schedule (180) 180
oncology (166) 166
kidney failure, chronic - complications (162) 162
pharmacology & pharmacy (155) 155
hematinics - adverse effects (153) 153
renal dialysis (153) 153
anemia - chemically induced (150) 150
hemoglobins - metabolism (149) 149
dose-response relationship, drug (148) 148
animals (147) 147
chronic kidney disease (147) 147
hemoglobins - analysis (146) 146
aged, 80 and over (145) 145
care and treatment (143) 143
anemia - blood (142) 142
cancer (140) 140
neoplasms - drug therapy (136) 136
anaemia (130) 130
antineoplastic agents - adverse effects (130) 130
erythropoietin - pharmacology (126) 126
quality of life (126) 126
drug therapy (119) 119
darbepoetin (118) 118
neoplasms - complications (114) 114
chronic kidney failure (113) 113
medicine & public health (112) 112
retrospective studies (109) 109
prospective studies (106) 106
kidney failure, chronic - therapy (100) 100
research (100) 100
chemotherapy (99) 99
hemodialysis (98) 98
hematology (97) 97
injections, subcutaneous (94) 94
kidney diseases (94) 94
general & internal medicine (93) 93
medicine, general & internal (90) 90
time factors (88) 88
analysis (87) 87
erythropoiesis - drug effects (87) 87
risk factors (87) 87
cardiovascular system & cardiology (84) 84
erythropoietin - economics (84) 84
nephrology (82) 82
randomized controlled trials as topic (82) 82
anemia - complications (80) 80
erythropoietin, recombinant (78) 78
health aspects (75) 75
erythropoietin - pharmacokinetics (74) 74
dosage and administration (73) 73
abridged index medicus (71) 71
cardiac & cardiovascular systems (71) 71
renal insufficiency, chronic - complications (71) 71
injections, intravenous (64) 64
internal medicine (64) 64
chronic disease (62) 62
transplantation (62) 62
double-blind method (61) 61
darbepoetin alfa - therapeutic use (60) 60
hematinics - economics (60) 60
recombinant proteins - therapeutic use (60) 60
medicine, research & experimental (59) 59
research & experimental medicine (59) 59
epoetin (58) 58
complications and side effects (57) 57
mortality (57) 57
anemia - therapy (56) 56
clinical trials as topic (56) 56
follow-up studies (56) 56
kidney failure, chronic - blood (56) 56
blood transfusion (55) 55
dialysis (55) 55
hematinics - pharmacology (54) 54
prognosis (54) 54
erythropoiesis (53) 53
heart failure (53) 53
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1397) 1397
Spanish (36) 36
French (26) 26
German (17) 17
Japanese (13) 13
Polish (6) 6
Russian (6) 6
Italian (5) 5
Korean (4) 4
Hungarian (3) 3
Portuguese (2) 2
Chinese (1) 1
Czech (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 03/2013, Volume 368, Issue 13, pp. 1210 - 1219
In this trial, patients with systolic heart failure and anemia were assigned to receive either darbepoetin alfa or placebo... 
MORTALITY | CONTROLLED-TRIAL | CITY CARDIOMYOPATHY QUESTIONNAIRE | EPOETIN | MORBIDITY | REDUCTION | DOUBLE-BLIND | CHRONIC KIDNEY-DISEASE | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Shock, Septic - etiology | Double-Blind Method | Heart Failure, Systolic - drug therapy | Hematinics - therapeutic use | Erythropoietin - therapeutic use | Heart Failure, Systolic - mortality | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Erythropoietin - adverse effects | Hematinics - adverse effects | Male | Thromboembolism - etiology | Erythropoietin - analogs & derivatives | Stroke - etiology | Anemia - drug therapy | Treatment Failure | Female | Aged | Darbepoetin alfa | Anemia - etiology | Hemoglobins - analysis | Heart Failure, Systolic - complications | Heart failure | Usage | Care and treatment | Anemia | Patient outcomes | Diagnosis | Clinical trials | Patient safety | Hemoglobin | Thromboembolism | Patients | Heart diseases | Cancer | Index Medicus | Abridged Index Medicus | Shock | Systolic/mortality | Hematinics/adverse effects | chronic heart failure | Erythropoietin/analogs & derivatives | Thromboembolism/etiology | Klinisk medicin | Heart Failure | Anemia/drug therapy | Hematinics/therapeutic use | Erythropoietin/therapeutic use | Hemoglobins/analysis | Anemia/etiology | Erythropoietin/adverse effects | Stroke/etiology | Clinical Medicine | Systolic/complications | Septic/etiology | Systolic/drug therapy
Journal Article
Nephrology, dialysis, transplantation, ISSN 0931-0509, 2007, Volume 22, Issue Supplement 4, pp. iv2 - iv9
The distinct molecular structure of darbepoetin alfa, in both its amino acid sequence and its carbohydrate content, results in a biologic profile with lower binding affinity, longer circulating half... 
Transplantation | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Erythropoietin - pharmacology | Erythropoietin - administration & dosage | Erythropoietin - analogs & derivatives | Anemia - drug therapy | Animals | Injections, Intravenous | Hematinics - pharmacology | Humans | Injections, Subcutaneous | Darbepoetin alfa | Erythropoietin - pharmacokinetics | Hemoglobins - analysis | Index Medicus
Journal Article
PharmacoEconomics, ISSN 1170-7690, 2006, Volume 24, Issue 5, pp. 479 - 494
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 12/2011, Volume 124, Issue 25, pp. 2903 - 2908
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 11/2009, Volume 361, Issue 21, pp. 2019 - 2032
.... This placebo-controlled trial randomly assigned such patients to receive darbepoetin alfa or placebo... 
ERYTHROPOIESIS-STIMULATING AGENTS | RANDOMIZED-TRIALS | RISK-FACTOR | ANEMIA CORRECTION | CLINICAL-TRIALS | CARDIOVASCULAR-DISEASE | HEMODIALYSIS-PATIENTS | RECOMBINANT HUMAN ERYTHROPOIETIN | EPOETIN-ALPHA | UMCG Approved | STAGE RENAL-DISEASE | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Erythropoietin - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Erythropoietin - adverse effects | Male | Renal Insufficiency, Chronic - complications | Erythropoietin - analogs & derivatives | Anemia - drug therapy | Stroke - chemically induced | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Anemia - etiology | Diabetes Mellitus, Type 2 - complications | Double-Blind Method | Hematinics - therapeutic use | Kaplan-Meier Estimate | Neoplasms - mortality | Hematinics - adverse effects | Renal Insufficiency, Chronic - blood | Kidney Failure, Chronic - epidemiology | Kidney Failure, Chronic - prevention & control | Aged | Darbepoetin alfa | Hemoglobins - analysis | Type 2 diabetes | Complications and side effects | Outcome and process assessment (Health Care) | Drug therapy | Cardiovascular diseases | Risk factors | Hypertension | Hypotheses | Transplants & implants | Patient safety | Kidney diseases | Diabetes | Blood diseases | Index Medicus | Abridged Index Medicus
Journal Article
Pediatric Nephrology, ISSN 0931-041X, 3/2016, Volume 31, Issue 3, pp. 443 - 453
Journal Article